Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3228 |  IMRX Immuneering Corporation - Class A Common Stock | 5.21 USD | -1.70% | +2.36% | +18.95% | +8.54% | 337.07 M USD | ||
| 3239 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.25 USD | -3.75% | -2.69% | -11.88% | +16.45% | 335.77 M USD | ||
| 3240 |  YDES YD Bio Limited - Ordinary Shares | 4.77 USD | +1.71% | +48.14% | +115.84% | -40.38% | 337.66 M USD | ||
| 3254 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.46 USD | +1.87% | +20.53% | +43.68% | +114.12% | 328.17 M USD | ||
| 3275 |  IRD Opus Genetics, Inc. - Common Stock | 4.03 USD | -0.49% | +10.71% | +30.84% | +8.33% | 335.28 M USD | ||
| 3286 |  VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.28 USD | 0.00% | +1.15% | +1.93% | -4.52% | 319.24 M USD | ||
| 3332 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.60 USD | -1.84% | +6.67% | +5.96% | -1.23% | 300.63 M USD | ||
| 3348 |  AVXL Anavex Life Sciences Corp. - Common Stock | 3.12 USD | -3.70% | -1.89% | +29.46% | -67.19% | 289.14 M USD | ||
| 3357 |  ACIU AC Immune SA - Common Stock | 2.84 USD | -2.07% | +12.25% | +26.79% | +33.33% | 288.95 M USD | ||
| 3359 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 10.21 USD | +1.69% | +10.98% | +27.78% | +11.46% | 308.91 M USD | ||
| 3364 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.82 USD | -0.26% | +1.06% | +1.60% | -44.48% | 291.46 M USD | ||
| 3382 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.39 USD | +2.58% | -9.47% | -4.02% | +104.27% | 286.37 M USD | ||
| 3401 |  SRZN Surrozen, Inc. - Common Stock | 23.62 USD | -1.54% | -0.46% | +16.13% | +105.57% | 277.62 M USD | ||
| 3402 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.35 USD | -2.91% | +1.24% | +23.53% | +5.45% | 286.18 M USD | ||
| 3403 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.62 USD | +1.69% | +0.10% | +11.99% | -3.80% | 286.56 M USD | ||
| 3407 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.82 USD | -0.26% | +1.33% | -12.39% | +92.93% | 273.79 M USD | ||
| 3414 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 1.99 USD | -2.45% | +2.58% | -1.97% | +63.11% | 275.17 M USD | ||
| 3420 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.09 USD | 0.00% | +0.93% | +3.81% | -36.63% | 275.67 M USD | ||
| 3422 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.33 USD | -3.48% | -6.46% | -9.51% | +26.14% | 270.60 M USD | ||
| 3424 |  IVVD Invivyd, Inc. - Common Stock | 0.93 USD | -7.00% | +27.40% | +52.46% | +75.47% | 274.13 M USD |
Notizie Biotechnology Stocks
Il titolo azionario di Alto Neuroscience raggiunge il massimo storico a 35,42 USD
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.06 | +635.71% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 APRE Aprea Therapeutics, Inc. - Common Stock | 0.78 | +21.88% |
 GOSS Gossamer Bio, Inc. - Common Stock | 0.18 | +20.00% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.59 | +16.06% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.76 | +13.55% |
 NTRB Nutriband Inc. - Common Stock | 5.29 | +13.28% |
 CRDF Cardiff Oncology, Inc. - Common Stock | 0.98 | +11.36% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0041 | -54.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.21 | -23.41% |
 ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.89 | -21.26% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0928 | -15.48% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.31 | -14.63% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.50 | -14.00% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |